The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsiao, F. C.
Right arrow Articles by Huber, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsiao, F. C.
Right arrow Articles by Huber, B. T.
The Journal of Immunology, 2006, 177: 2056-2060.
Copyright © 2006 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Epstein-Barr Virus Transactivates the HERV-K18 Superantigen by Docking to the Human Complement Receptor 2 (CD21) on Primary B Cells1

Francis C. Hsiao*,{dagger}, Miao Lin§, Albert Tai{ddagger}, Gang Chen{ddagger} and Brigitte T. Huber2,*,{dagger},{ddagger},§

* Programs in M.D./Ph.D., {dagger} Genetics Program, and {ddagger} Immunology Program, and § Department of Pathology, Tufts University School of Medicine, Boston, MA 02111

EBV, a ubiquitous human herpesvirus, is the causative agent of infectious mononucleosis and is associated with many carcinomas. We have previously shown that the EBV latent genes LMP-1 and LMP-2A (for latent membrane proteins 1 and 2A), transactivate a human endogenous retrovirus (HERV), HERV-K18, in infected B lymphocytes. The envelope (Env) protein of HERV-K18 encodes a superantigen that strongly stimulates a large number of T cells. In this study we report that HERV-K18 env is transactivated even earlier in the infection process, before the establishment of latency; namely, we found that EBV, through its interaction with its cellular receptor CD21, induces the HERV-K18 env gene in resting B lymphocytes. This transactivation is direct and immediate, as up-regulation of transcripts can be detected within 30 min after EBV exposure. Thus, EBV binding to human CD21 on resting B cells triggers the expression of an endogenous superantigen. The biological significance of this superantigen expression for the EBV life cycle is discussed.




This article has been cited by other articles:


Home page
Microbiol. Mol. Biol. Rev.Home page
C. Voisset, R. A. Weiss, and D. J. Griffiths
Human RNA "Rumor" Viruses: the Search for Novel Human Retroviruses in Chronic Disease
Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 157 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Butler, N. Wertz, P. Weber, and K. M. Lager
Porcine Reproductive and Respiratory Syndrome Virus Subverts Repertoire Development by Proliferation of Germline-Encoded B Cells of All Isotypes Bearing Hydrophobic Heavy Chain CDR3
J. Immunol., February 15, 2008; 180(4): 2347 - 2356.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. D. Lunemann, T. Kamradt, R. Martin, and C. Munz
Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?
J. Virol., July 1, 2007; 81(13): 6777 - 6784.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.